04/23/2008 Jamie Li, Ph.D., Director, Urology/Gynecology R/D
Boston Scientific
The Practical Part of Biotechnology
04/16/2008 Michael A. Davitz, M.D., J.D., Partner
Axinn, Veltrop & Harkrider LLP
The Role of Intellectual Property in the Pharmaceutical and Biotechnology Environment
04/09/2008 Aseem Anand, Biotech Alumnus
Clinical Trial Coordinator, MSKCC, and Founder, BioTrak
Organizational Issues in Biotech
04/02/2008 David Best, M.D., M.B.A., President, and Michael Banks, M.D., Vice President
MDea, Inc.
Careers in Medical Communication and Big Pharma
03/26/2008 Alan E. Smith, Ph.D., Senior Vice President, Research, Chief Scientific Officer
Genzyme Corp
Therapies for Genetic Diseases
03/12/2008 David Sable, M.D., Fund Manager
Special Situations Life Sciences Fund
Investing in Biotechnology: Inside a Life Sciences Hedge Fund
03/05/2008 Michael Rice, Senior Consultant
Defined Health
Cardiovascular Franchises: Too Much Risk in Prevention?
02/27/2008 Greg Homison, Ph.D. Director of Research and Technical Services
Department of Biological Sciences
Infrastructure:  From the Mechanical to the Interpersonal
02/20/2008 Angelos M. Stergiou, M.D. VP Product Development, Medical Affairs & Clinical Research
Accentia Biopharmaceuticals
Treating and Curing Patients, Clinical Research and Development
02/13/2008 Daijin Kim, M.B.A., Associate Director, Healthcare Informatics
Pfizer Human Health
Challenges & Opportunities in the Pharmaceutical Industry
04/25/2007 Ross Grossman, Ph.D., M.B.A., VP, Human Resources
Regeneron Pharmaceuticals, Inc.
Organizational Issues in Biotech
04/11/2007 Ivica Labuda, Founder and President
Biokeys for Flavors, LLC
Biotechnology Role in Flavor Industry
04/04/2007 Kelly Wines, Associate
Fitzpatrick, Cella, Harper & Scinto
Intellectual Property: Where Technology Meets the Law
03/28/2007 Jerry Di Salvo, Distinguished Senior Research Associate, Department of Immunology
Merck Research Laboratories
A View from the Bench:  Basic Research and Drug Development
03/21/2007 Melanie Rolli, M.D., Director, Brand Safety LeaderIntegrated Medical Safety,
Novartis Pharmaceuticals Corporation
From Bench to Bedside: The Process and the People that Turn an Idea into a Drug
03/07/2007 Vivien Marx, Science Writer
Science Writing
The Art of Describing Science to the World
02/28/2007 Chau Cheng, Ph.D., Associate Director, Investor Relations and Business Analysis
Immunomedics
Investor Relations in the Biotech sector. What is unique about it?
02/14/2007 Nelson Scharadin, Investment Banker Healthcare Investment Banking, Oppenheimer & CoFalling forward in the business of Biotechnology
02/07/2007 Heather Butts, Regulatory Specialist, Institutional Review Board, ColumbiaUniversity
Bringing it all together: issues in research ethics, history and review
04/26/2006 Gary Shangold, M.D.President & Managing MemberConvivotech, LLC.
Creating Your Own Career in the Life Sciences
04/19/2006 Ron Guido and Alan McEmber, Directors, Worldwide Regulatory Strategy
Pfizer
Pitfall Avoidance: Regulatory Affairs as Tactician in Biotechnology Product Development
04/05/2006 Eugene Trogan, Ph.D. Biotechnology Analyst
Ursus Capital Management
Biotech and the Savvy Investor: How to Stay with the Good and part with the Bad
03/29/2006 Thierry Teil, M.D. Executive Director
The Medicines Company
Pharma and Biotech Industry: Overview & Opportunities for Biology Graduates
03/22/2006 Steve Dinh, Sc.D. Vice President, Research and Technology Development
Emisphere
Oral Delivery of Protein Therapeutic Molecules
03/08/2006 Eliene Augenbraun, D.O., Ph.D. CEO and President
ScienCentral, Inc.
Bite Size Biotech – how most Americans learn about science
03/01/2006 Philip Braginsky, J.D. Of Counsel
Sills Cummis Epstein and Gross
The Commercial Realm of Patents
02/15/2006 Holly Hilton, Ph.D. Research Informatics, Genetics and Genomics
Hoffmann-La Roche Inc.
The Role of Functional Genomics in Drug Discovery
02/10/2006 Marie Teil, M.D. Director, Clinical Trials Office
Mount Sinai School of Medicine
Drug Approval Process -from an FDA perspective or from a pharma point of view
02/08/2006 Jeff Yablon, Principal
Yablon Management Consulting/PharmaScan Clinical Trials, LLC.
Introduction to Clinical Development & Biotech Management Concepts
02/01/2006 Lata Jayaraman, Ph.D. Senior Research Investigator
Bristol-Myers Squibb
Choosing a Career in the Bio-Pharmaceutical Industry
04/27/2005 William Fair, M.A. VP, Healthcare & Biosciences
New York City Economic Development Corp.
Commercial Bioscience in New York
04/20/2005 Josh Xiao, Ph.D. Sr. Scientist
Amgen San Francisco
High Throughput Screening in the Functional Genomics Era
04/13/2005 Ivan Oransky, M.D. Deputy Editor
The Scientist
Biotechnology and the Media
04/06/2005 Costa Papastephanou, Ph.D. President and COO
Ortec International
The Anatomy of a Biotech Company
03/30/2005 Linda Armstrong, M.D. Medical Director
Pfizer
Assessing Drug Safety: From Bench to Blockbuster
03/23/2005 Mark Kay, M.D., Ph.D. Director, Human Gene Therapy Program
StanfordUniversity
Gene Transfer Strategies for Treating Hemophilia and Viral Hepatitis
03/09/2005 Allen Fienberg, Ph.D. Founder & VP, Business Development
Intra-Cellular Therapies
Reflections on the Transition from Academia to Corporate Life
03/02/2005 Michael Yamin, Ph.D. Director, Technology Development
Warren Pharmaceuticals, Inc.
Tissue Protective Cytokines from Discovery to Development
02/23/2005 Jeff Margolis, President
Aurora Capital LLC
Start-up and Early Stage Biotechnology Companies: Translating Science into Products
02/16/2005 Charles Ryan, Ph.D., J.D. Executive Director, Chief Patent Counsel
Forest Laboratories, Inc.
The Role of Intellectual Property in Pharmaceutical Drug Development
04/21/2004 Eelco A. Slagter, M.S. Director of Science and Technology
AMDeC foundation, inc.
Developments in the Biosciences: An Integrative Approach
04/14/2004 Ramana Sonty, MBBS, Ph.D. Senior Director, Worldwide Development
Pfizer
Integrated R&D/Commercial Cross-Functional Approaches to Strategy, Portfolio and Risk
04/07/2004 Rene Baston, M.A. and Matthew McCooe, M.B.A., Associate Directors
ColumbiaUniversity Science and Technology Ventures
Technology Transfer - Making an Impact
03/31/2004 Sundeep Bhan, President and CEO
Medsite, Inc.
Exploring Entrepreneurial Opportunities in Biotechnology
03/24/2004 Nicholas Giorgio, Ph.D. Senior Director of Protein Sciences
ImClone Systems, Inc.
A Brief History of Erbitux, from the Lab Bench to Aapproval and Beyond
03/10/2004 Melanie Rolli, M.D. Associate Director, Clinical Research
Novartis Pharmaceuticals
From Bench to Bedside: The Process and the People that Turn an Idea into a Drug
03/03/2004 Mary Morry, Ph.D., J.D. Senior Attorney, Intellectual Property Litigation
Merck & Co.
Patents and Practical Tips for Obtaining and Using Them
02/25/2004 Ilya Trakht, D. Sc. Chief Research Consultant
Acceptys
Totally Human Antibodies: from Bench Science to Biotech Business
02/11/2004 David Sudolsky, M.B.A. Principal
Sudco Consulting
Adventures of a Serial Biotech Entrepreneur
02/04/2004 David Weinstein, Ph.D., M.D. President and Chief Scientific Officer
GliaMed Inc.
Biology-based Drug Discovery in the Nervous System
01/28/2004 Charles Jennings, Ph.D. Executive Editor
Nature Research Journals
The Role of Journals in the Communication of Science
04/23/2003 Louis J. Capezzuto, J.D. M.A.Patent Law Department
Johnson & Johnson
Biotechnology Patents 101- The Basics
04/16/2003 Uwe Scherf, Ph.D. Director, R & D
Gene Logic
Whole Genome Expression Profiling: Generating and Utilizing High Quality Data
04/09/2003 Nezih Cereb, M.D. Executive VP and co-founder
Histogenetics, Inc.
Clinical Implications of Polymorphism of the Human MHC (Major Histocompatibilty Complex) Genes--Industrialization of Molecular Tissue Typing
04/02/2003 Don O’Sullivan, Ph.D.  Senior Account Executive
Euro RSCG Life NRP
Communicating Biotechnology-the value of public and investor relations in the life sciences industry
03/26/2003 Rene Baston, M.A. and Matthew McCooe, M.B.A., Associate Directors
ColumbiaUniversity Science and Technology Ventures
Technology Transfer from Academia
03/12/2003 Tina Lopingo, Ph.D.  Director, Technology and Business Development
New York Biotechnology Association
New York’s Biotechnology Landscape
03/05/2003 Julie Kan, Ph.D.  Senior Research Investigator
OSI Pharmaceuticals
The ‘omics’ World for Small Molecule Cancer Drug Discovery
02/26/2003 Bharat Mehta, Ph.D. VP Manufacturing Operations
Genta, Inc.
Regulatory Requirements in Pharmaceutical Manufacturing with Focus on Critical Utilities and BSE/TSE-Viral Safety
02/19/2003 Andrew Marshall, Ph.D. Editor
Nature Biotechnology
The Vision of Genomics and the Reality in Drug Development
02/12/2003 Timothy Howe, M.B.A.  Partner
Collinson Howe &Lennox Medical Partners
Venture Capital in the Biotechnology Space
02/05/2003 Rudolph Spangler, Ph.D. Senior Research Associate
RockefellerUniversity
Designing an Efficient High Throughput Gene Expression Technology
01/29/2003 M. Timothy Cooke, Ph.D. M.B.A. CEO
Mojave Therapeutics
Creating Value: Business Models in Biotechnology
05/01/2002 Anthony J. Russo, Ph.D. CEO and General Manager
Noonan/ Russo
Public Relationship in Biotechnology
04/24/2002 Hillel Cohen, Ph.D. Director, Drug Regulatory Affairs
Novartis Pharmaceutical Corporation
The Role of Regulatory Affairs in Development of Biopharmaceuticals.
04/17/2002 Kenneth H. Sonnenfeld, Ph.D. Partner
Morgan and Finnegan
The Swinging Pendulum of Biotechnology Patent Law: What’s patenable and What’s Not
04/10/2002 Robert Crowl, Ph.D.
Novartis Pharmaceuticals Corporation
Genomics and Drug Target Discovery Facing the Challenge of Osteoarthritis
04/03/2002 Frank Carrigan, Ph.D. Beth S. Kauderer, Ph D., J.D. Mathew McCooe, M.B.A. Director and Associate Directors
ColumbiaUniversity Science and Technology Ventures
Risk in the Capital Transformation Process
03/27/2002 George D. Yancopoulos, M.D. Ph.D. President, Executive VP and CSO
Regeneron Pharmaceuticals
Merging Biology with Drug Discovery in Obesity, Inflammation, Angiogenesis, Muscle Disease & Other Setting
03/13/2002 OSI Pharmaceuticals
Field trip
03/06/2002 Young WhanPark, Ph.D. Research Fellow
Merck Research Laboratories
Current Techniques in High Throughput Screening for Drug Discovery Processes
02/27/2002 Jean Denaro, M.A. Project Manager
Pfizer Pharmaceuticals
Clinical Research: Methods and Opportunities
02/20/2002 Harmen Bussemaker, Ph.D.  Professor
ColumbiaUniversity
Computational Analysis of Genome Sequences and DNA Microarray Data
02/13/2002 Alex Elbrecht, Ph.D. Research Fellow
Merck Research Laboratories
Compound Characterization Using Gene Microarrays
02/06/2002 Ron Cohen, M.D. President, CEO, Founder and Director
Acorda Therapeutics
So You Want to Start a Biotech Company, Hmmm?
11/28/2001 Jules T. Mitchel, Ph.D. President
Target Health, Inc.
Principles of Drug Development: a case study in AIDS
11/19/2001 Raymond S. Fersko, J.D.
Mints, Levin, Cohn, Ferris, Glowsky & Pepeo, P.C.
Commercializing Biotechnology
10/01/2001 Meirav Chovav, M.A. M.B.A. Managing Director
Credit Suisse First Boston
Biotech, A Business Built on Science
04/25/2001 Shubha Govind, Ph.D. Professor
City University of New York, CityCollege
Drug Development Using Flies and Model Organisms
04/18/2001 Conrad Gilliam, Ph.D. Professor
Columbia GenomeCenter
Identification of Genetic Loci of Human Diseases
04/11/2001 Bernie Yurke, Ph.D.
Lucent Technologies
Assembling Nanostructures and Nanomotors out of DNA
04/04/2001 Rene Hen, Ph.D. Professor
Columbia University Department of Pharmacology
Animal Models for Diseases
03/28/2001 Robert Pearlman, Esq.
Intellectual Property Causes
Patenting
03/21/2001 Stuart Fischer, Ph.D.Research Scientist
Columbia GenomeCenter
High Through-put Physical Mapping
03/07/2001 Juergen Hammer, Ph.D.
Hoffmann-La Roche Inc.
Gene Chips and Applications
02/28/2001 Victor Lin , Ph.D.
ColumbiaUniversity Irvin CancerCenter
Transgenic Mice Facilities
02/21/2001 James Russo, Ph.D. Research Scientist
Columbia University Columbia Genome Center
The Human Genome Project, Genome Sequencing, and Disease Gene Discovery
02/14/2001 Chris Adams, Founder and President
Mosaic Technologies
Entrepreneurship in Biotech Industry
02/07/2001 Eric Schon, Ph.D. Professor
Columbia University Department of Genetics and Development
Molecular Genetics of Human Mitochondrial Disease
01/31/2001 Cy Stein, M.D. Professor
Columbia University Department of Medicine
Theory and Practice of the Antisense Biotechnology
01/24/2001 Donald Landry, M.D. Professor
Columbia University Department of Medicine
Anti-cocaine Catalytic Antibodies
01/17/2001 Arthur Bank, M.D. Professor
Columbia University Department of Medicine
On the Road to Hematopoietic Stem Cell Gene therapy